Literature DB >> 10496963

The importance of a nitrogen atom in modulators of multidrug resistance.

G Ecker1, M Huber, D Schmid, P Chiba.   

Abstract

The presence of a nitrogen atom, charged at physiological pH, has frequently been considered to be a hallmark of P-glycoprotein (PGP) inhibitors, although certain steroids, such as progesterone, lack a nitrogen atom and still are active modulators of PGP. The present study was aimed at investigating the role the nitrogen atom plays in the activity of PGP inhibitors. Propafenone-related amines, anilines, and amides that cover a broad range of pK(a) values, as well as an ester, were synthesized and tested for multidrug resistance-reverting activity. The sum of the hydrogen bond acceptor strengths was calculated and correlated with EC(50) values for PGP inhibition. For the complete set of 12 compounds, an excellent correlation between these two parameters was found; this included the ester GP570, which lacks a nitrogen atom but contains the strong hydrogen bond-accepting ester unit. The interaction of the nitrogen atom with PGP therefore is nonional and is determined by the sum of the hydrogen acceptor strengths of the region. The high predictivity of the obtained model is demonstrated in a leave-one-out cross-validation procedure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10496963

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

1.  Physicochemical properties and transport of steroids across Caco-2 cells.

Authors:  Fried Faassen; Jan Kelder; Johan Lenders; Rob Onderwater; Herman Vromans
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

2.  MCASE study of the multidrug resistance reversal activity of propafenone analogs.

Authors:  Gilles Klopman; Hao Zhu; Gerhard Ecker; Peter Chiba
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

3.  Molecular dissection of dual pseudosymmetric solute translocation pathways in human P-glycoprotein.

Authors:  Zahida Parveen; Thomas Stockner; Caterina Bentele; Sandra Pferschy; Martin Kraupp; Michael Freissmuth; Gerhard F Ecker; Peter Chiba
Journal:  Mol Pharmacol       Date:  2010-12-21       Impact factor: 4.436

Review 4.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog.

Authors:  Atsushi Kodan; Tomohiro Yamaguchi; Toru Nakatsu; Keita Sakiyama; Christopher J Hipolito; Akane Fujioka; Ryo Hirokane; Keiji Ikeguchi; Bunta Watanabe; Jun Hiratake; Yasuhisa Kimura; Hiroaki Suga; Kazumitsu Ueda; Hiroaki Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

6.  A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.

Authors:  Fabio Broccatelli; Emanuele Carosati; Annalisa Neri; Maria Frosini; Laura Goracci; Tudor I Oprea; Gabriele Cruciani
Journal:  J Med Chem       Date:  2011-02-22       Impact factor: 7.446

7.  Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism.

Authors:  Hiroshi Omote; Marwan K Al-Shawi
Journal:  Biophys J       Date:  2006-03-24       Impact factor: 4.033

Review 8.  The remarkable transport mechanism of P-glycoprotein: a multidrug transporter.

Authors:  Marwan K Al-Shawi; Hiroshi Omote
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 2.945

9.  4-Isoxazolyl-1,4-dihydropyridines exhibit binding at the multidrug-resistance transporter.

Authors:  Victoria Hulubei; Scott B Meikrantz; David A Quincy; Tina Houle; John I McKenna; Mark E Rogers; Scott Steiger; N R Natale
Journal:  Bioorg Med Chem       Date:  2012-09-25       Impact factor: 3.641

Review 10.  Structure-activity relationships and quantitative structure-activity relationships for breast cancer resistance protein (ABCG2).

Authors:  Yash A Gandhi; Marilyn E Morris
Journal:  AAPS J       Date:  2009-07-24       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.